HomeOwner SearchCategory Search
Visit USCOASSAY and Drug Development Technologies [Published: 2011-10-11 to 2011-12-15. Issues: vol. 9, no. 5, October 2011 to vol. 9, no. 6, December 2011]
Serial Registration
Copyright Title
ASSAY and Drug Development Technologies [Published: 2011-10-11 to 2011-12-15. Issues: vol. 9, no. 5, October 2011 to vol. 9, no. 6, December 2011]
Status
Published
on 12 Mar 2012
Year of Creation
2011
Copyright Claimant
Mary Ann Liebert, Inc
Registration Number
TX0007515443
on 12 Mar 2012Copyright Summary
The U.S. Copyright record (Registration Number: TX0007515443) dated 12 Mar 2012, pertains to an electronic file (eService) titled "ASSAY and Drug Development Technologies [Published: 2011-10-11 to 2011-12-15. Issues: vol. 9, no. 5, October 2011 to vol. 9, no. 6, December 2011]" created in 2011. The copyright holder is Mary Ann Liebert, Inc, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Mary Ann Liebert, Inc.
Application Details
Registration Number
TX0007515443
Registration Date
3/12/2012
Year of Creation
2011
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Mary Anne Liebert, Inc
First Publication Nation
United States
ISSN
1540-658X
Notes
Copyright Local Holdings: vol. 9, no. 5, October 2011 Pub. 2011-10-11 Reg. 2012-01-18 TX0007515443 JMOOvol. 9, no. 6, December 2011 Pub. 2011-12-15 Reg. 2012-01-18 TX0007515443 JMOO
Statements
Application Title Statement: ASSAY and Drug Development Technologies
Author Statement: Mary Ann Liebert, Inc employer for hire Authorship: Collective Work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.